Patent No. EP3749353 (titled "Nemolizumab In The Treatment Of Atopic Dermatitis With Moderate To Severe Excoriation") was filed by Chugai Seiyaku Kabushiki Kaisha on Feb 8, 2019. The application was issued on Jul 30, 2025.
A pharmaceutical composition for treating atopic dermatitis in subjects with one or more moderate to severe skin excoriations comprises nemolizumab or an equivalent thereof and a pharmaceutically acceptable carrier. An equivalent to nemolizumab is defined as an anti-IL-31RA antibody meeting any of the following criteria: (i) $\ge$55% amino acid sequence identity in heavy chains, (ii) $\ge$55% identity in light chains, (iii) $\ge$55% identity in variable regions, (iv) $\ge$55% identity in complementarity-determining regions (CDRs), (v) binding to the same IL-31RA isoform (optionally the same epitope) as nemolizumab, or (vi) blocking or neutralizing IL-31RA. Nemolizumab is a humanized monoclonal antibody that inhibits interleukin-31 signaling by binding to the IL-31 receptor subunit alpha (IL-31RA).

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
| Company | Opposition Date | Representative |
|---|---|---|
| CABINET BECKER ET ASSOCIES | Apr 30, 2026 | CABINET BECKER ET ASSOCIES |
| J A KEMP | Apr 30, 2026 | J A KEMP |
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Oct 21, 2026
Oct 21, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 4, 2026
Sep 4, 2026
Sep 4, 2026
Jun 29, 2026
Jun 29, 2026
Jun 29, 2026
Jun 29, 2026
Jun 23, 2026
Jun 23, 2026
Jun 23, 2026
May 18, 2026
May 18, 2026
May 18, 2026
May 8, 2026
May 8, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Apr 30, 2026
Aug 12, 2025
Aug 5, 2025
Jul 15, 2025
Jul 15, 2025
Jul 15, 2025
Jul 3, 2025
Jun 19, 2025
Jun 19, 2025
Jun 19, 2025
Jun 19, 2025
Jun 19, 2025
Feb 25, 2025
Feb 25, 2025
Feb 25, 2025
Feb 25, 2025
Feb 25, 2025
Feb 25, 2025
Jan 11, 2024
Jan 11, 2024
Jan 11, 2024
Jan 11, 2024
Jan 11, 2024
Jan 11, 2024
Sep 1, 2023
Sep 1, 2023
Aug 22, 2023
Mar 3, 2023
Apr 2, 2021
Apr 2, 2021
Apr 2, 2021
Apr 2, 2021
Apr 2, 2021
Feb 3, 2021
Dec 23, 2020
Dec 23, 2020
Dec 23, 2020
Dec 23, 2020
Nov 18, 2020
Sep 25, 2020
Sep 23, 2020
Sep 23, 2020
Sep 23, 2020
Sep 8, 2020
Sep 8, 2020
Sep 8, 2020
Sep 8, 2020
Aug 24, 2020
Jun 19, 2020
Sep 2, 2019
Aug 15, 2019
Aug 15, 2019
May 29, 2019
May 29, 2019
May 29, 2019
May 29, 2019
May 8, 2019
May 8, 2019
Apr 8, 2019
Apr 8, 2019
Mar 26, 2019
Mar 7, 2019
Mar 7, 2019
Mar 7, 2019
Mar 7, 2019
Mar 7, 2019